REPORT ID 6958

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2017

Publish Date
1-Nov-17
Pages
95
Format
Electronic (PDF)

In this report, the United States Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in these regions, from 2012 to 2022 (forecast).

United States Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine & Radio Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GE Healthcare
    Philips Healthcare
    Siemens Healthcare
    Toshiba
    Hitachi
    Carestream
    Esaote
    Shimadzu
    TriFoil Imaging
    Biosensors International Group, Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Diagnostic Applications: SPECT, PET.
    Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2017
1 Nuclear Medicine & Radio Pharmaceuticals Overview
    1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
    1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals by Product Category
        1.2.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
        1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    1.3 United States Nuclear Medicine & Radio Pharmaceuticals Market by Application/End Users
        1.3.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Diagnostic Applications: SPECT, PET.
        1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
    1.4 United States Nuclear Medicine & Radio Pharmaceuticals Market by Region
        1.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
        1.4.3 Southwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
        1.4.5 New England Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
        1.4.6 The South Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
        1.4.7 The Midwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Nuclear Medicine & Radio Pharmaceuticals (2012-2022)
        1.5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2012-2022)
        1.5.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Nuclear Medicine & Radio Pharmaceuticals Market Competition by Players/Suppliers
    2.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Nuclear Medicine & Radio Pharmaceuticals Average Price by Players/Suppliers (2012-2017)
    2.4 United States Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends
        2.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate
        2.4.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Region (2012-2017)
    3.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Region (2012-2017)
    3.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Region (2012-2017)

4 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2012-2017)
    4.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Type (2012-2017)
    4.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) by Application (2012-2017)
    5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application (2012-2017)
    5.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Nuclear Medicine & Radio Pharmaceuticals Players/Suppliers Profiles and Sales Data
    6.1 GE Healthcare
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Philips Healthcare
        6.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Siemens Healthcare
        6.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Toshiba
        6.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Hitachi
        6.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Carestream
        6.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Esaote
        6.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Shimadzu
        6.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 TriFoil Imaging
        6.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Biosensors International Group, Ltd
        6.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Nuclear Medicine & Radio Pharmaceuticals Manufacturing Cost Analysis
    7.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Type (2017-2022)
    11.3 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Application (2017-2022)
    11.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer